+ All Categories
Home > Documents > Techniques for Measuring - Dissolution...

Techniques for Measuring - Dissolution...

Date post: 27-Apr-2020
Category:
Upload: others
View: 12 times
Download: 0 times
Share this document with a friend
10
Techniques for Measuring In Vitro Release From Semisolids Abstract Joel l. Zatz , Ph .D. and Judith D. Segers , M. S. Rllfgt'n ()I Pblll'IJIlli)' fJ/I'mtflZm.\'. , \7 -f)edimlrd 10 Ibe IIWIIIO!), oI L orl'ltfi Kmlo- Tbe I C-S',\; gllit/IIII({'. 7.!,birb gUi .. 'tTII,f Jm/e-fl/1 (flld pO.l't-apprU1.'111 (/.IlIlIgcs.lor .I'('III;sulirl.l', requircs ill 1.';11'0 rl'lm,\'(' dffta ;11 cerllfill im-I((I/(('.I" u/rbllllp:t' ill fbi' 111/101111/ oflfll (,xcipi- ('lit, b"tr/.l ,1'; :' (, or Jl/llllltjilclllrillg (''llfipllli'lIf, pron's.I' or sitl'. 77)(' I.:iueticf ofllll lI{fit'" ingrediellt tbroflgb {/ ,w'lIIi.wdid illlo (I liqllid .I'il/A' (1/;(' rcap/or) tire JIIt'tlSIIIW/; fill illel"l. 1'01'0/1.1' 'III/'II/flr(fl/(' .l'l'/J"mtc,\' ,be /71'0 pbt/scs. S'l't'cml (ommercial illslrlllllclIls • .rOIl/!' OI7tbicl; iJl(OrpoJ"((II' /lu/al/lllted /0 /III ill.l'lrtf/IIt' III. lire "'-'IIi/"MI'. The priJ/tiplll experilJleNtlll daisirJII.i· illi 'oh'c ,fc/lYI iOIl uI (('1II- pl'rllwr(', 1JIl'lJIbrtllll', I'('((' ptor fllld tilJling 0I.wIIJlpkJ. 'fb('JI' should be (busl'1l 10 millimi:!' IIndcsired iJlfl'rtlrtioll.f tllld 7I//I/",l' Ibroll,!!,:b Ibe ,ft'IIIisvlid mlc -lill/ilill,!!" ,\'O Ibtll Ib t' imrifl.fi( rc!ell,I'{, i .1' Jl/l'II,l'IIrct/. /)lItll /I'l'1IfIllt'1II im ..'oli:l '.1' ploffing Ib(' {IIIIOllllt relcII ,f l'd IIgllill.I'1 Ill(' ,1"If/lln' root V Ilillll ' lIud !Ising Ibe .Iiop/' oflbe liJlt ' IIJ' plot 11,1' fill iJld{'.\', Nett'llse praj/It'.I' IJ/ffJ' be (£'rltl;1I dUlJlp/.f ill IJ/flllItjil(/lIrillg Ol'j(WlJllllll liulI. Introduction In \ilro n:l c.l'iC fnJlll \1 .. u,llilcd;1..,,, coun tcrp:1rt to t:lhkl di'isnlmion. In hoth ledlllique.." Ihe of drug n.:Ie:lsc From a form into:1 ..,ink :In.: dctl:rlllim.: d. The r Cl:c plor .'.olutiol1 /()r.1 dOS:lgl ' unit 1Il:1)' h l' \illlulated g:h tr ic /luid or:1 llIodilicllion th ereof. in recognit i()n of the f:l ct th:lt :1 tahlct or :Hlmini.., tcn. :d or:llly "p cn ds somc timc in the \10111<lch. Ill\ 'l''i li g:llnrs IIU} colllrol e\per imclH;11 con dition ... 10 'ic:lI'c h fix:1I\ in \itro- in \ i\'o corrc hlLion u\l:ful in furt h er product dnelopmclH :lnd E;.;peril1lellts of in \'itro rcle:l'ic from scmisolid'i :Iln:mpt to IlH::I'illrt> in importuH ... i ca l propert ies dUI Illay h l' relate d to topical hio;l\' aibhility, 1 1 0\\ (;\cr, Illt..:a - sur elll ent collditiom do not Illimi c physiolog'ic reality. In particlllar, thc in vi tro rclt..::lsc 'ietup not include :I mcmIJr:lnc r esc mhlin g th e ':i kin \ I) ll':llUrn corneUIll,:1Il dt:tcrrnin,lllt of ':ikin penetr:1tioll char - actcri .. tics, Thcn:t()!'I ,:, in vitro n:ic:lsc is llot a !(lr :1 clinical or hio;I\';libhility st1ldy. Ilhkad, ill \ill'(} rele:l ... e prO\ id e.'. information dependcnt upon certain phy\icil attributcs :1Ilt! shou ld bi.: considcred all t..:xtcn\ioll of other phy.;;i cal l1l e:lslIn':l1le llt s, such as rhwlof..',), and p:micl e \izl'. Pharln:l CCunc.l lll l:l1luf:lct1lrcr .... : Irc cur r ently not rC{luired to \u hlilit in \ itTo rclt..::I\e data:l'i part of : In "I' . \1\.ID.\ . The SCPi\C-SS guid:lIlce, \\hich gm-erm scale-up :mel POSl-:lppr()\- al changes for non-\tl'riic sCllli ... olid.." require.., rclc:bc d:na in ce rtain in"I,lIlcc .... of cha n ge in the amount of an cxci piclll, hatch \izc or m:lIlut:Jcturing equ ipment, or site. (A cn p)' of the guid,1Ilce Illay he ohtaincd hy \\riring to the FDA Oflice of ' li'aining :1I1d COl1ll1lunica- riom, j)ivi'iiol1 of COllllllunic:uioll\ .\I an<lgclllcnt. Dru g Inforrn,"ion B ranc h IIFD -2 10, ;GOO Fi,hm Lane , Ruchille , , \11) 2(JH5i, It CIIl hc £10\\ nlo;1(leci from: http:// \\\\\\,fd:l.gmA:dL:r/glJid;lllce/index.htlll,) L ack of :1 ..,ig-ni!iclIll difference in rclea ... e, along with sim ila r re\uh ... I()J' other tCSb, i\ :In ind ication th:ll such hare l1olll1:1lerially altered product :Ilt ri htl te .... The III mC:hunng III ril1'O release from ..,r.:lIli..,ol id.., arc: :1) rhe h) Ihe c) thl: colltiitiom (Iemperaturc, l1lembr:lIlc, rcccptor, 'i:unplc timi ng) d) :Hl,llr ... i.., of rh e d:Il:1 R cg-,mllt..:..,\ of til{': ,lpparaws lIsed, the semiso lid s:11llp le is 'illPpOrll:tI bY:l thinlllL:lIlhr:mc \1 hich scp:lrate .... it from :I liquid (thc rcct..:plOr), into \\hich th e actin: difFuse..,. The re('elHOr i'l salllpled periodically :lnd assayed to gi\'e a lime-dependent rei<..:,\sc prolile. A rcli:lhle, reproducihle, \' alida tcd drug ,ISS:l}, essential in ge ncr:lling the d:H:I on \\ hich all will he I ll gh perfnfll1:lllct: lilluid chromatography (I JPLC) is the Illethod cO lll1llonly u\cd, for hoth accuracy and Cllll\cnicllce. :llthuugh g.l .. chnllnatography : Intl other tt:chniquc\ ;I re po..,..,ihililic.., in C<1"'C\ \\here all I IPI.C nOi .'.uit:lhle. i ... :111 important i'i>'uc if thc r:lle of release b sitm or thc drug cOllcentration \'cry 10\\', a C(II11nlOn occurrence \\ ith (nf,{/crn lopical produCb. From theoretica l ton ... ideratioll<j:, :1 plOl of the alllount relc:lsed \'<;, lhe \qU:1n.: root of time expi.:ctcd to he line:lr afler;lll iniliallag period, The ..,Iope of the l in e,lr portion of the curvc i .'. ,\J1 index of the n:lc:J':ie and :1 logicil WIIIIIIIICd".fJtl,ff,I' r; II /)i.'''·(} /lIfi (}I/'/i-dJllo/ugic,.-!FE BR UARY 1 99H dx.doi.org/10.14227/DT050198P3
Transcript

Techniques for Measuring In Vitro Release From Semisolids Abstract

Joel l. Zatz, Ph.D. and Judith D. Segers, M.S. Rllfgt'n C(JII(~!!;t' ()I Pblll'IJIlli)'

fJ/I'mtflZm.\'. ,\7

-f)edimlrd 10 Ibe IIWIIIO!), oILorl'ltfi Kmlo-

Tbe .')'U/~ IC-S',\; gllit/IIII({'. 7.!,birb gUi .. 'tTII,f Jm/e-fl/1 (flld

pO.l't-apprU1.'111 (/.IlIlIgcs.lor .I'('III;sulirl.l', requircs ill 1.';11'0 rl'lm,\'('

dffta ;11 cerllfill im-I((I/(('.I" u/rbllllp:t' ill fbi' 111/101111/ oflfll (,xcipi­

('lit, b"tr/.l ,1'; :'(, or Jl/llllltjilclllrillg (''llfipllli'lIf, pron's.I' or sitl'. 77)(' I.:iueticf ~rdij]i15ioll ofllll lI{fit'" ingrediellt tbroflgb {/ ,w'lIIi.wdid illlo (I liqllid .I'il/A' (1/;(' rcap/or) tire JIIt'tlSIIIW/; fill

illel"l. 1'01'0/1.1' 'III/'II/flr(fl/(' pl.~l'.I'i({//~l' .l'l'/J"mtc,\' ,be /71'0 pbt/scs. S'l't'cml (ommercial illslrlllllclIls • .rOIl/!' OI7tbicl; iJl(OrpoJ"((II'

/lu/al/lllted Imll_~Fr /0 /III '1II11~)I(j{(f1 ill.l'lrtf/IIt'III. lire "'-'IIi/"MI'.

The priJ/tiplll experilJleNtlll daisirJII.i· illi 'oh'c ,fc/lYI iOIl uI (('1II­

pl'rllwr(', 1JIl'lJIbrtllll', I'('(('ptor fllld tilJling 0I.wIIJlpkJ. 'fb('JI' should be (busl'1l 10 millimi:!' IIndcsired iJlfl'rtlrtioll.f tllld 7I//I/",l'

d~1.1i,si()1l Ibroll,!!,:b Ibe ,ft'IIIisvlid mlc- lill/ilill,!!" ,\'O Ibtll Ibt' imrifl.fi( rc!ell,I'{, i.1' Jl/l'II,l'IIrct/. /)lItll /I'l'1IfIllt'1II im..'oli:l'.1' ploffing

Ib(' {IIIIOllllt relcII,fl 'd IIgllill.I'1 Ill(' ,1"If/lln' root VIlillll' lIud !Ising

Ibe .Iiop/' oflbe liJlt 'IIJ' plot 11,1' fill iJld{'.\', Nett'llse praj/It'.I' IJ/ffJ' be flll!'I'('{II~l' (£'rltl;1I dUlJlp/.f ill IJ/flllItjil(/lIrillg Ol'j(WlJllllllliulI.

Introduction In \ilro n:lc.l'iC fnJlll 'icllli~() lid 'i m:l~' I)c \1 .. u,llilcd;1..,,,

coun tcrp:1rt to t:lhkl di'isnlmion. In hoth ledlllique.." Ihe kinelic~ of drug n.:Ie:lsc From a d()~:lgl: form into:1 ..,ink :In.:

dctl:rlllim.:d. The rCl:cplor .'.olutiol1 /()r.1 ~olid dOS:lgl' unit 1Il:1)' hl' \illlulated g:htric /luid or:1 llIodilicllion thereof. in recognit i()n of the f:lct th:lt :1 tahlct or c:\p~ll l c :Hlmini..,tcn.:d or:llly "pcnds somc timc in the \10111<lch. Ill\'l''ilig:llnrs IIU} colllrol e\perimclH;11 condition ... 10 'ic:lI'ch fix:1I\ in \itro­in \ i\'o corrchlLion u\l:ful in furt her product dnelopmclH :lnd t c~tillg ,

E;.;peril1lellts of in \'itro rcle:l'ic from scmisolid'i :Iln:mpt to IlH::I'illrt> ('hallgc~ in importuH ph~ ... ica l properties dUI

Illay hl' related to topical hio;l\'aibhility, 1 10\\ (;\cr, Illt..:a­surelllent collditiom do not ll~llallr Illimic physiolog'ic reality. In particlllar, thc in vi tro rclt..::lsc 'ietup doe~ not include :I mcmIJr:lnc rescmhling the ':i kin \ I) ll':llUrn

corneUIll,:1Il c~!)en tial dt:tcrrnin,lllt of ':ikin penetr:1tioll char­actcri .. tics, Thcn:t()!'I,:, in vitro n:ic:lsc is llot a ~lIh':it irure !(lr :1 clinical or hio;I\';libhility st1ldy. Ilhkad, ill \ill'(} rele:l ... e prO\ id e.'. information dependcnt upon certain phy\icil attributcs :1Ilt! should bi.: considcred all t..:xtcn\ioll of other phy.;;i cal l1l e:lslIn':l1le llts, such as rhwlof..',), and p:micle \izl'.

Pharln:lCCunc.l llll:l1luf:lct1lrcr .... :Irc currently not rC{luired to \uhlilit in \ itTo rclt..::I\e data:l'i part of :In ~D. \ "I' .\1\.ID.\ . The SCPi\C-SS guid:lIlce, \\hich gm-erm scale-up :mel POSl-:lppr()\-al changes for non-\tl'riic sCllli ... olid.." require.., rclc:bc d:na in certain in"I,lIlcc .... of change in the amount of an cxci piclll, hatch \ izc or m:lIlut:Jcturing equ ipment, procc~~ or site. (A cnp)' of the guid,1Ilce Illay he ohtaincd hy \\riring to the FDA Oflice of ' li'aining :1I1d COl1ll1lunica­riom, j)ivi'iiol1 of COllllllunic:uioll\ .\I an<lgclllcnt. Drug Inforrn,"ion Branch IIFD-2 10, ;GOO Fi,hm Lane, Ruchille, ,\11) 2(JH5i,

It CIIl hc £10\\ nlo;1(leci from:

http:// \\\\\\,fd:l.gmA:dL:r/glJid;lllce/index.htlll,) Lack of :1 ..,ig-ni!iclIll difference in rclea ... e, along with

simila r re\uh ... I()J' other tCSb, i\ :In indication th:ll such m'lnllEll'llIringdl;lng~'i hare l1olll1:1lerially altered product :Ilt ri htl te ....

The elellJelll~ in\'ok~d III mC:hunng III ril1'O release from ..,r.:lIli..,ol id.., arc:

:1) rhe :I"'''',I~ ' h) Ihe :Ippar:ltu~ c) thl: colltiitiom (Iemperaturc, l1lembr:lIlc, rcccptor,

'i:unplc timing) d) :Hl,llr ... i.., of rhe d:Il:1

Rcg-,mllt..:..,\ of til{': ,lpparaws lIsed, the semisolid s:11llple is 'illPpOrll:tI bY:l thinlllL:lIlhr:mc \1 hich phy~ic:lllr scp:lrate .... it from :I liquid (thc rcct..:plOr), into \\hich the actin: difFuse..,. The re('elHOr i'l salllpled periodically :lnd assayed to gi\'e a lime-dependent rei<..:,\sc prolile.

A rcli:lhle, reproducihle, \'alidatcd drug ,ISS:l}, i~ essential in gencr:lling the d:H:I on \\ hich all conclu~ioll\ will he h:l~ed. I llgh perfnfll1:lllct: lilluid chromatography (I JPLC) is the Illethod mo~t cOlll1llonly u\cd, for hoth it~ accuracy and Cllll\cnicllce. :llthuugh g.l .. chnllnatography :Intl other tt:chniquc\ ;I re po..,..,ihililic.., in C<1"'C\ \\here all I IPI.C <1s~ay i~ nOi .'.uit:lhle. ;\sSil~ ~l'nsitirity i ... :111 important i'i>'uc if thc r:lle of release b sitm or thc drug cOllcentration \'cry 10\\', a C(II11nlOn occurrence \\ ith lnan~' (nf,{/crn lopical produCb.

From theoretical ton ... ideratioll<j:, :1 plOl of the alllount relc:lsed \'<;, lhe \qU:1n.: root of time i~

expi.:ctcd to he line:lr afler;lll iniliallag period, The ..,Iope of the line,lr portion of the curvc i.'. ,\J1 index of the n:lc:J':ie procc~~ and :1 logicil

WIIIIIIIICd".fJtl,ff,I' r; II /)i.'''·(} /lIfi(}I/'/i-dJllo/ugic,.-!FE BR UARY 199H

dx.doi.org/10.14227/DT050198P3

In Vitro Release from Semisolids ... continued "",,,.,,J ,.; .. ,", , .. ,' , 1",,""1" r, Ir" "'w"' i,, ~ I'"~" '" d",c~"'n<) i "" of. ill ,," '" n ' " " f J m"It,. Th" ",., ,, C'I~" l1l ",, 1 lim, , m',,] ,I,," I""" "tI ... 'I" II", ,, " "'gk """""'IL)(" ', ",<1 ,1'(JLlld, <I,ereioIT, I" II",re " I=<hil, ,, ",J rl'i iol,1o til .. " .,,\\ "f lik' i , ~ li " id "JI ,'"k, .~ ,\, d"",,;!x<I '"~ " "; it ;,; ilnl' ''tctnt ,,, ,t.-:."". ",,,,,,,,",,n[ """li t""" th " ,,~~,I ,k· 'lItnm>:: reb,,· dur.>.",,," " ' lHl t o) ", I", ,he- ".-r(~t Y."', ,, , "f ,I,,' pcb", ,""" "..-, ,,,,1 ),,-, ,

II. Technique: Apparatus and Procedures A. Apparatus l)">ig'" - !l.e,·k" ~" "" r",, \ ' ! l' ~g'" "f "I'"'''''' fn, "'LkiyillR ,Idill"", of lC!n',

tn~",I;",," from ",,,,,,,,,1, I",,, '1'1',,,,,,1, " thc- li llTlllLtt'. 111 ~l' lIl' "

.1. ,1,,·," ",Ite",; "JII,i" "I , d,,~,.. cd l ~h i (f1 hnjJ, rh' ,,,"i,,,bl "" " ',i , l, m il " """'j~(J r ,:,,11 (~ ""'I,mlll'''H wh:.:n h< "h rl l<' ,1>",-" "-"'I"" " 'l,li"," ,,,,lin.,, " ' 1i ,'n """pic> m ' wit h,l"wn . , "'p ,l" [11 ",'1""1;. ' Ihe s,.,'c"" "HI' , " '''') ,,," " ,,· I"Jc, ""mh" ,,,, ·~' I"",, i l1g ,he I " '0 I,h,,.,,. ,",I Ill"'"' "I I!' n'i"~ , ",I " "ltr"l l i,, ~ rI", ""'I>cT""rc "I Tk ""'1'M """l iUI11,

I 1 "I~ll "th) I ,,,,, I,,,,, ,) I"" Mfll s;"" ",II ,," J=ihl ," 1'16-1, in wh irl> ,,,", -1,,,'00, ''''''1'' 11 111.'''''. ,"'" ,,-, ",,i,,i l\~ dl< oil1tl11,O[ l)Clll~

""Ii , ,1 "".I th, nth", """""lng the "~~l''''' 11,,1, Wl'rt ": I",~,c.I I,!, , "l'ni,-.I 'lIl'lILbr,mc JLKI KTun'J wi,h I>"b l Tilt ,nU," ce ll ~'" n"",,,,,1 ulf ,\ ,h,h" i" . ;11'(: i""" I"'ilT r", "gi",i,," ,nd 'CIl 'I "'''' ,UI'{' """,,,,I.

[li I W,,~ . 'j''''''''~ '' ,"","'il"'" wh,,,, ri ' l' ~,' II I ", i "~ ""kd ~w, ""p),,,,,"";n , I'",,,i di 'n "", I )' I ,,~ , I '" J J.{~X~ ", II >c"',, LIlll,,,,,,,d ill • J;'C w",,, h,, 'h l , 'Il", ,,"c'pt".- LIl,diu" , ~'4' I" uml dir,xtJ) ti lt"

'h, Iot,k" " "I ~,~ " ir",1 ~' i, " " "" ,I, il,Ir· I>I", I,· bl" ",,,-,,,. "Ir"" "" "" stirril\g 1>1,, 1, ", ~i(k, ., ,h<; Petri ,bh_ III th " ~')' "1' I" '" ,,,'" """,I),,, l ",rI. ,~,,,,,1 ~Ll1"1t"" ,,,i>ly,

.\ ",,1'1I[ b l"",,,, r} "' 1\"""'"'' '" ",".II' ,,~.,., f,,"n " "T"'enll ,,,,,J " ,-""'-<J<U>C~ " ioH11"" i.lt " d" , ~ "n'" """'llJ~">cnt, ,n", ~·h;rn ,,,,cOl i,,,", w" 1"",,,,,1 ~·i,h, mhl", gde' , ,,,I ,,, '1""H<.>1' li ,P.

11" li lkJ cdl w" tI"" " ''l'~", 1 " 'i,h " ch,np ' '' " r i, ,~ """d , ,, d ; ""''', r"" I i" , n n " 1>'''''' illg ,I i < h "",t , i n i ng ,r..' ""~ 1"'''- ",-, iJ ", Ll

In, 1'171 '''I''''' 'ld~''' L ", II , J e" , "'"Ie ,,, " I 0,4"" ,h~ we", 1I 'k'd i<)r " ,, "v i "~ " "'"", "I ~ '" "''''1<,,1, In "" ,n .. ,,,,,.-I. '\ ,".,111""", ,,,",I I", '",'IL '(' '' 'W eT , h,' crun1 wi,h , ' let],," ri" •. 'Il Lc ,,011< Wl',e

Ll1"""",.1 in , 1Xl ml "I "~q)\"r Ilu,d, '~i, ,,,d " i,h 1,1,,1, "'''l' '',. ", b." ,"" l'l~ i" , l 1°(: ~"Cf I"th

All", ,t"in l"" ,-"d cdl .;>1 ",m in ,lill11"" (l~p"i')" ,"1 \ will"]' held . """,k",,, ""I """"le'" ""I w;< "'''''l''',,,,, '" • ;, .. \ .,,,,,1 "",,\,'1' of 'I i, ,,<oJ r' ''''pl<.>1' II ,, ", " :,, ",,,J In ,t ,,,h the " b"" "f " Ii , (~;Ii,' "';'1 In"\(~"'''K" ',5, '11,,-, ",II m't<",1 w", ,-ht""" m ,,, ,,, imi,, ~"'I""lL ,~. ", li c)'1 1< >cjJ,

Hl'leo", of 'k..-o<O ,In'g' "~l l< tld,,1 '" "in1l1~"" I " ~,,~ ,, ""bl "'Ln~ " fl" '1",1,," .Ii':' .' "" in ,1","",,,1', ()"""K':l ' "" lLld" wl'," ~ 1 .-c,,1 '" , ,il", 6.\'0<' '" lhe I ' J1\, ,, " ur , h, ,1 i,h, " l.icIt ~';' d"", inve~·

.,,1 ",I ~,,,,,,I 0" d,,' ,,, Ii,,,,< "I ,he '"''1''''' ""d i,m,

& " i,mllron bel,m' b~ """oEK,tic "i"i,,~ b,"

I ",'c,t;t" OO ", d.<' ,"~ ,he ,dc,,;,,' " '" of k,) I",. IT('i· " "I f",,, " ,nllHC"fH< " """ ,,1 the' "I' en,1 01, !0 -1I11 1" ,lyuh); "",' ' ~' m'¥' , Med tl", I ~ rrcl wiLl ' "i",,, ,",,,,

/),_,,mli1l,,,il;·dJlJ/),,,!.,.-slH:'B R C,\ R\ I \1') ,

d""ld d,,' l~'m~'" "n,) '0' 1;\ 1' d i ;~,J"H'''' ' 1"<"'''''', i"Hl"",,,1 ,I" 'H'''''''''' ""I m ' '' '' I>trJturc'-" ,,,wdlcd """i'"'' 11",1 ;lnJ M,lt­oJ Lill' ,''' " I' k; "1 ill fJ." , ,

,'\rrm11 " ' ,<" ,t "d \ d,,,~ "·b,,,, I~ ,,, ,"""" il1 ,I"'n" '''''''' ~'ith th,· ", eq'''''- 1'1,,0« I'~ ,;,,,, ,, I , t,,-h" "I'~' wh",I ~' "''''' <"" 1>1 ,·, <1_",1.1 be ' I",,, J (xltu ' "Il~ ''l' "';1I1~'i >1,;,,1 >cr,," , " . 1 "",'n ,," ""'­

,;.:,I i)· i'>lo , " I", Ih ," 1'),0' ,-h~ 'l\J ,wc' I,jW ,I1."d'1'''',' d\"nl >Ol fi lh l ,,,,h ""'1''''' m,,,Ii'" 11 " ,,,,,I In,,, th e 1, ,,,,,,, II'lth, "'H<>_ ' 1t'~ ' ''' ''c ~"flll " w,~.

,\1,~I ; r"al 'on, "f Th , S, ,.tor iu, :I!>sorj1l i'''' Sin"d.!,,,, , ,b>c" d""~,,,, 1 '() " "",I, ,, m "" " g"",m"di ,,,,1 ,1"'''1, i,,,, "I ,Iru~'-1,,\·, ["" , "11,1"" to II" "",I,' ,i drc~ Jifr"~U " froll "",,, ~,l iJ,"· IU In d,," w 'l'j1li ,'01ior;< , 'h" ,I";>()L" I~""" "' '' h,1.1 i t> . "'''' , I"'nl~", ""I "-l",r;'eu I ~' • '~'u-"", ,,h,,,,,, '~" "lI L (h,l'd'''p",li "li l",!, hi l",) i,,,,,, ri" "-'t'-'I"''''' " ",I i,", wl" , h r io: "I ",,<I ,hr"I):I, J fl,nH I" \J u" I, " ,II "" the '-'I1W'" ;:,k.

[n 1'107 , ," "I I "'~'"I ,,,~ I g""U",,, for m eim 1 ~f"(",J""'lb l"-'lIl" ", i"" ,,",h ~-'" l.e",,,,,,1 "J' ,be Fr . , I ;t,d I)",," ,I,j"""i'lr:t-1;';'" ",d ,he ,I""" i,," Aw>ri", ", "f I'h" "n""' ",i ,,1 '",' t"IS" I, F,,.. MI",,,,, ""II d""gn . ,ho ;1uth "" "".,m",nd 'h ,,'

"Thl' '" .. to .. , JiIT";"n ,·d :, ,"'(JIII J be ,,,,,Ie, r~J'" men. " .. >On" ,­Ii", ",,,,,,,i,l , ("" h" ~ I ,,,, ",i""" ","" I. I,~",, :, Incl1 " '''' ltd d ,b~"I''""':' w ,II "'''1 ''"''''< "f 'h, ,~II. lI>:.i <>li"g fk", -,hr< i<ld, Ii, ,,, 01 ,,1 the- ""leu i"" ,·hmd <'CI rlIl',,, ;,,,I,'c<, <1,uuJU he J~' " ' ' ""' '''[­d I~' "' I><ri",,,,,, . Ir ,h" "I,1 , :~, he ,""",." Ih" '"''''' ;,. ,w 1 ,~",L l m~ Ih" " 'b,j, it, ,'" I"i li,,. dum,. 01", I'CfLlIl'Jt;m 1",,,-,,1:,fl' . If " ,,,j l i' ~ ~ • I".) ,b n," 4"'IIl i",i,·0 ,,,:c,,,,, , t i" ~ of ,hi, ''' ' N I", ",,,), . ' I'h, "-"' IX"" """li ll'" >h;.,,1 1''' '''i<l,, ;111 dr('<1 il'< ,iLll hlhe I'-~ ''''''H lrbll,l'. it ,h"uld, " ,I., "'-' ''l' till>:, t"n'"", , ,, ,,,,,,IIUIl1 '(J lu" " W

f.,:, I i u, e ,,," Ii'~' 1,,,,,,,",,,. 11\ !1"'~" "I , I h l' """" (U \<:('('1m ",I d II' en' ,~

ill ' ''' <o ll ,,,, i')I1 "di" ", ,h" r"", i" "'''r Th, ""II "" i,lOl ,h",1:1 , Ih,w 'he '"~ I ~''' 11,, "1 ,,, ho well ",,,,,I "',[ '''''1''' ''''''0 ""' ­""IIe,d,"

,\ I!hwgh """",,-" II 'l "d,.', ", i,'I: I\If . li l"",<" "" "I d ... \~n ,~" 'Y" t·",,, dNrihe,1 ,I,,,·, h,,, I"",,, rt'l"m,,1 m romot ,,,,,,,,, li,r), H.I' .I'.",I"i '!.)'!': I,::, t~·o d",;p ' t q~', h,H'" ,!"",,,, ,h,

""'" 1~~Gl1 i ,1 in, ""-'" ~", lm li ""l, ,'n "'I""~ li , l ll ,,, 'h .. k "on i,',1 diffusi,m cdl; f(Jr """',"fl'lI '" '' 011""'-"';<"''-'''' .1B. , ~)\i< .. ii,,,,, I'""" , ... 1 "' ,,lili,,1 Fro",.), ~ hcl "'(I"'''' "'" of , """,he,,1' ~'kl\ ",c"",m'g d~". ft'I"",-,. , "d it:l1lH,i"" «,II, li,.- "'" '' ILl> the " ,11111".,1 US], 1);,~,IUl'''" .\I~"M'" li,l'" LI ,,' blLKl'l E"blll'Cr Ce ll " " I "" 11.,,, ,,-,< . 0;"",,,,,,, Cdn, whirh ' 0"-1' I" ",,-,I "i ,!, ,or ~' il h, "" " ".(." ,_ brll"'. 111 1',*' ,0., feN 'qut "I t:", Ii i(' "I 'he Fell17 d,Iii,~,," ".,11 , " , l""cu,i,1 'l,e,li ,), ",""n, j)f"(x'"I"" '" ch,e.>C'ml.l' LI", ",b,,: Ikh"i .. ,,' "f " '1'",,1 J,~",'" r",,.,1\1 "" I,,,h li,bld 'j h, rn!>." .... ·.., (.,11, 11Hn,I"",,1 il1 l'j ),H ;111,1 tr" I Ll1l~'" ( I"" "","" Coli ", "",,1 "" """b d l Sl' ,I;"",l u';,,1I ' 1'1""' '''' ' 1'1", r." ", ,,.Jl't 01 ",,' ",,'c­

,i"" u il l d. senl. , III ,1"t;1i l the p"" "" I""" h ",0 ci m,,;,; [,.I'" ')1" .' of 'Y" " '" ,,) ,,,",, ,,,, in< 111 , ' i.'r'~ Lin," de-,,,, fm" ",,,i~)l i, 1<.

IL l'nK'"h",,, _ ,"e"cr,1 Cn,,<idcrJt"'"' Tb"",-~ I "{I"""''' '' '' '' f,o ,,, I,,,!, I h, d,oi",' of "'l',"hw" "",,'­

rill ""I """l~'" (""' I~~ i,j,", , ... 1 t"" 'I,, " "I l'\' >n' pre, "" ,,,1 ill

Section In belo\\'. !\lc.:1l1bralH: rn:lt~rial:-, \\'hich 11:Ivc Ill:cn u<icd inclutil' n~'lon , ccllulo:.e, cdllll()~c aceta te, mixed ccllulol!c ester, P\1)F, PTFE, pol}l)ropylcnc, polysu lfol1c. acrylic copolymcr, and vinylmcI­ril:el. ,\Iemlmlllc pore si/c i~ genc!':l!l)' U.-J.5 ~1l11 hut call vary. Receptor mcdium temper;HtlI'c.., typit'ilily used ;In.: 32, 37, or 25 C.

Sampling 1\ ith n:pbcel1lt.:nt or the receptor medium i~ done:lt reg-­IIlnr intervals, cither 11l ;lrlu;l lly or by means of alllOJll:lt:ion (see Section c:. helow). Appropri:1te 'i:llll pling timc illtcrv:1ls \':11)' with the :Iclive component's solubility in the receptor medium :Ind rnembr:me per­meability, and mm[ he dClennim-:d experiment:lll}'- ' 1 ~'PiC:ll sampling" i nten';l l ~ :H'C n.15, 0.5, 1,1,4,6, and R hour.." ahhollgh a dur:uioll of greater dun 24 hour.., 1ll:IY he l1l:n:S~'lry. 1\ 1I101'!.! dct,lilcd disCllS~ioli of timing issues is gi\cn lJelO\\ in Section III.

S:ullples of receptor mcdiulil are then <l~'i,l}lcd ror the :lctive ingre­dielll by the :1ll:1Iytic11 IlH':lhod of choice; II PLC, U\' spccrros<.:opy, and galllJll,1 scintigT;lphy :lre r~llical. D:lt<l an:d)'sis prirnaril~1 invol\,c"l plotting the CU1llUbli\'c ;11l1()ulll of dmg n.:Ie:1sed per ullit are;1 of S;IIll­pit' \''i. 'iquare roOI of time. The resulting plot should be linear in agreement II ith the r.:qu:ltion., of J l igudli~'·!6 for diffu.,ioll-contnllle<1 release of drug prc.,cn t in 'iultpen..,ion

Q = (1 C" C Dt)1 /2 , C, « c" W'I' II or in solution

Q = 2 C" (I)t!rr) 1/2 I E'I' 11 1\ here Q = amount of drug rele:lscd per unit :1J't.:a of sample, C1, =

inili:ll concentration of drug in semisolid, C.., = soluhil ity of drug in semisolid matrix, D = diffll..,ion cocfficiem of drug in ..,cmisolid, :lJld t = elapsed timc.

C. Procedures - Apparatus Specifics and Auto111ation II lTlodilied Franz diffu<ion cell (Crown Cia" FDC-+OO) is illus­

l1'atcd ill Figflre I. A similar cell is the I hlll SOll 57-VC \ 'erticd Diffu ~ion Cell. T11I.: cel l hody consists of :'l j:lckt:ted ghlss receptor

Open to Air

Cell Cap (Donor) ----- [.t-lh Thin Finite Dose ----____

IsotOniC Saline Skin +9~ Solution Chamber

Water Oul

Water Jacket -

Cell Body (Receptor)

37°C Water In Sllrrlng Bar

Saline Solution Injection Port

Figurc 1 . . \ \nd iti..:d fr:HlI diffu,ion cell (FDC-4(}()). (Rel'm/ltd (olIr'I'.~l' o{ CrOii'll Glllss ComplII~V. 11If. )

chamb~ r, 12.5 1111 in volullle {modified cell., ex i')l with ~ Ii ghtl}' diA'er­enr recepror volumes) and :1 gbss sampli ng por1. The memhr~lI1e i'i pl:lced horiwnt:llly over the receptor (hamher, the cel l cap is :lpplied

Ol'e1' Ihal, :md the c()mpont![1\~ are Elslened together with a met;11 clamp. The te~t l<lI'Illublion can then be applied in a cunrrollcd alllounl \\ ith :1 s~Ti ngr.: to thr.: .,u rElCr.: memhrane through the top of Ihe cdl cap, \\ hich i.., opcn to the atillosphere unless 'iealed hy the u..;er . . \n altc rn,lti\e method of s;unple placcment is to u.,r.: a circular telllplatl: having :1 di:lI11cter rn:lt<.:hing dut of the cell opening. The template is lISr.:d:l~:1 cOllI rolled-depth die into 1\ hich the formulation rn:ly hl! evenly lilled nn :1 Iln ..,urf:lCe using a sp:lIub and then invert­ed :lIld pbced on thl.' lIlernhr:lIlc.

.\1 the bottom of the re(cpw1' chamher a rnicro-rnat,'1letic stirrer is pbced. The entire cell i'i pmiticlIlr.:d in a multiple-cdl dri\'e unit whJeh dril c.., the rn;If,'1letic .,rirr·er to :l~ril;l[(: the rCl:eplOr medium :a a con­trolled rate. The iilckctcd porlioll~ of rnultiplt.:: cell., arl.' connected in scriL'''' \\ ith lUhing (() ;1 circlll:l ling' tcrnpcr,lUlre-controllcd \1 :Iter h:lth.

Autol1l:1ted s:lI11pling for ..,ystems using this type of cell is :lVail:lble from I lanson Rese:lrch :1.., the Microe.m: l()pical :lnd rn':ln ~derrnlll

Diffu:-,ion Cdl S~,.,tern. I" ~r.r./(n' '1 il! a schematic illu'Maliol1 of the auw-1II:lIed ..,~stcrn li)r (In(' diffu'iioll ndl. At progr;lIlUlled lime intcn'al.."

•.. " ... "_ ..... ,.,. .. "-,, .. .. " ,,," .""

:':~ ·I

~

Fi!-I'urc 2. I bn')on \ \icrocttc S;nnpling Sy~tcm. (Rt'pnllfrd CQIII1rsy of IIil/HOIl RI'.'l'IInb Corpol'lllioll)

,tirr'ing of the recepror IIlt..'dium 'itops, :l ~pt:citied volume of fresh medium i~ injected I'ia ;1 syringe pump, :md :lrl equ:ll volume of 5,1111-

pic i'i ..,irllLrlt<lIle()u~ly forCl.:d (lilt of Ihe ch~lInbcr, through sample tuhing and into prcc:lpped vi;ll~ in a carousel. The ~tirring then he~im ;lg;lin . . \ \\a..,h cyclc clean..; the sample line.., jll~t he fore the ..,alllpl ing ocnrr~.

Complete ;llItorn:lfion or "i:ulIpling and <l1l:llyo,i~ hao, been ;lCCOI11-

plbhed h}' illlerf;l(ing the ,\licroctle \\ ith \ Vaters I I PLC sy:.tcrm~~·~:-:, Sample 1\ ill1dr:III':1I, transfer, ,lIld II PLC inje<.:tion are coordinated via !"Ile \ \ ',11(,1':-' system controller, which ;llso cont,lins the I I PLC Illethod~ program"i for mohile ph~lse cOlllposition and now

rate, column lernper:Hurc, detcnor \\·,l\t.:!cngth and injector ~cqtrCllcc. S:ullplc IIPI,C ;lJl:lly~i., takes place hct\\ccn Ijillllpl ing lime,> \\'hile the di~solulion test proceeds COIl­

currcntly. AS";I~ dal;1 ;IC(]ui:-,ition and analys is ,Irc perl/mlled hy the unit'.., net\\orking cornputl:f sy':ltl.!l1l. A complete, fully autormltecl :-,ystcm can be ,lChicH'!d h}'

f)i.,·.\'{)I/llio/lTi:d)llol()Kies/ F I~ IlR UA RY 1998

In Vitro Release from Semisolids ... continued I;"b"." [h, ,\I i,,,,,,,o ~ "" D,,,~, 111.1'-'-' '1"'" to ,f>:, \1'""" .\",,)­m""1 11;"",I",;" ,, S" ,W".

Tip"" ! ,h""" "" '~'phlc,1 ,i"" of th ,> \'",, ~, I I',""' '' (T' (:,,1 "\':til")' "",1 ill I'I"'-~"""t In 'he l\lod iiic,1 !((i'IIl I R, ,,,I "f, ,tmri,,,1

~

ntr= , 'r-' · "-~.

· . · . , h ' • • : <;;l i :

lS I' Di,,,,III '["" IliUCU,';' I),"

", II , <,,,n1,,,,,·,1 "",,c~· "f Ellon ,<>m i,,, ,,( ." , ,Ji"",h l ,. "I"";'Y "'Illpic res .. ""., . • wOI I, ­," f,,,- ro<""~li ,,g

'"I""''] mTr.", ,re., "lLd ' '' '1'''' , ... :,,~'..., ' ''I' '" ".x"", tI," w" h" ,,,J "",,, I,e'"c " ,'cr ' h, '''' ' 1\10 n,.,,·t"\'"'' Th" 'y,w lI em I"

I ;;"" . j. I: "h, n(,·· (>' 11 \"cmht,-. :R.l"~.'."! "",-. "",.1 ~ itl\OtJ l " .'''1 of I,,· ~.·i ki.,J.,gr (;"'1..' ",,,,, hT,,,,' "'

IJilT it ,hicc'J. 'Th" ,~"" I!lc ,hi""" \' ,"lJl"~ or ,I.e n·IiI . "I)' ;, " Ii" '" <J " 'lIlg ' ' 1'-"" ''' ' ~-h i ('" illC'e""" <Y ,h,",,',,~ the .I,p,h of II", ",,,,,,.-,;, '11" tt " ~,.,,,u l ,,,, ,,, " 1;lIl,<1 into thc dl """ '"'' ~ "h the' .,1 "I" '1"",1, " , <A""i" " "",,,I,, elt" ,,,f,,, ",<1 (n ",ilL;m;"" ,he, 1' ~I; I ;lity .,1' ;" 'If I"hl>t.: I>:twc, '" the ""'pk " , rf>f~ ",,,I , I", "[,',11-Im,1O, ,\1",,,1,,, ,10, lI Ll'" I" cut ", , di ll ""e,- <If'11m.,,,, ,,,,,I), 10:",,, ,,, I Jy",, 1 ~ 'gh dy 0"0< I, ], d ~' lUI' of thc' "'Mer ~ I" " 1,,,,,,1 <~'C~ tlK' "' '' pk , ,, ,hoe_ The ",,, li l1g " "~ (",:" Iw) "' rI ",,, 1'1,,,,,, "" '''I' "I' ['" n'II I~, I, " ,,,I tI", ret,i ,,,, ,, ",'p,~'cxl.m ,,,I,, "nt; l 11 i,,,, 1<"ch" ,he ",,,,li nt ~"¥' '\ > 1~-ci,1 , li)"" ,,, ,, , ,.,,1 i; ,b ,""",1 ,I> I'WI"rI)' I ,~; ' im the "" I ",~ r i " ~ ",I """I the lll<mhrmc ,i~h d \' '" lh t "" "pie, ' Ihe '' ' ''pic-t(,1 , ,,0,,,101 ) " ,hen 1,10,,,,,1 i" ,he 1," t0:1 ' of [h< 211'1_In I '''' "II_ Ix,11'-'' '' ,1;,.,,,1,, ,,, ", '0'><1 ", (Il d", ,"" ,"h" "c/"''' 'IJc " ,tf",,-' 1",,, .,,1" ""I ,I>c , ,, ,, li li (,ll~ , \' lh : i, " ,,,,,,,",,1 If) , )l,-.,-" li"""I.I'I',h oJ l I "', .1""'0 ,he, cell. ,III "~,,,," I ) """"",,] ""Iu t:>!.' 01 "'~'p"'r modill n' "'hll I", I~'"" d"t,,,,<'J , 11,] ~" n,,,,, 1 if lIt'C"",,) lO ,he "c~ ,,,1 ttf11l",e""re " ",hi 11. 'f.,' 1'01",1, ,,~I [Ix.' 1",1,11c' 11>(",-"" ' .. ,,, ,,,,,J '''' tu t",,,,,, , d", 'c~ ,

Th, 11'"~ln Oil1 (me nl ( ~' II '" il lu"" ,n,,[ ill h:~ ",c f , II'hil , it ~ ,."" 1,, m ,b ie" ""I '1""" i, ," to t~, I'n~ ... '", Cd l, i, l"~""''';' '" lIl' ,"," hj c' .I i fi,,,c , ,,-'c,. Tn l' .I i <'<!/ !It;"" il ". " " l ) iJ-m] II ,,· I, ~. t, "" 11 .. " ~h i rn ,' 11 ,,, ,," til " (he <:ell ,,, ,f,,,,, ~ ill I. , I" c,1 rlm,,~I ,, )U ,

,ix., 'N ""d ", ini",,,,, ,he de,d "",m,, " 'rT(' "l1 li n ~ the Om ,"""n, Cell. ' ]1", ".Il'IJc ,,,m'.,i, uf rI ", ,-ell lUI 11".1 di' Llctl~m" ("," ,10,,1 " 1 'm ill ""f.-'" di ,m l'w ",I ; lllnl dqwh; ,"'-"'if", ,, ;.;.,, ore ",.i l­

II ,bI,1 to l '''''lrl' rei""""'"' ,,,,,pic ,'olu, ,,,-,- ' fl>e 'Pl'jd '" (' ," I,,, '\0 di ,m l'1 0< U[ ! 5 to " 11 .r<"" ,,, ,,xl,,,, """) "',,)­"' I'd Iii" III 'e, .1"",-

lu". "" ,d "" "I'lit:~ (If tl" ",-' ')"C"" ~'" he ,"-','OllL I'l i;l-.o,1 II\i" ~ 'h,' II. ,,,,,,, , I )i'~ !C~ ,,\ ~'ilid, ~ ,'or, ';llL; I,,-

IoDI<'T<> " '" ",,,,,,.,., ""~"'-lJll()O [(,,,,.,"'",

, .

- ,­""""'" """"" .~.

~

<l<,'" w • ....,. ,~-

0"". ,", ".""'" 0_

T ,"" '" .""-."" """" ""-"'" ""'S«."KlOI 'If H Al ..,,,"'"

h ~"" 4, I b ,N '" (l" """ ,,",, (A II '\ ," '" lJ )'_ i ,I',' ,"-'" ".F ,""' ,'" 'i ! I,' ",'''' RNI",.f, r:"i ...... ""';'

In "j""'" i '" '" tl", '\ j i ,'''''lI' J t's('~ G.d ,k .. ,-, , " I w hj , 11 I", been i" ~'L ,b]l rc>. 1 "," Iror l]SP (k~,] uwII' "",i,'S' fo, ' '' ' ")' _w"" ' 11 ", Di>­""""c 'ei" , I ~ , I .. , ,,, oc,I,,'ed with I II'LC ,,' U\' i FN tl); ' lclH' " '"

')~'"Fn ''-''''1''''''« I;", tl1, ,,1 '''''.o"'' ';'"" d "";,,~ J., ,brild ~ ,.- th ,' ,\l ie",<"o

;\ LI ,,,, ,, ,, ,, I """lH '''g ... 1 LtV ""Y ,,( ,1",,,I ,,,i ,,, '",Un" '''' . ",il_ , hie I h ru Ll ~h I 'J IlKt'l " d,c MJS !OCO:) ,\ u" ,,,,, ,,,1 I )"~ , I " ",,,,

An, I)," , SY'( 'lt_ F,,,- ,,,Il""","" "i "''''I''''!' oml ;n l c~," " , ,nit" '" II PIE " "I" "m, ,II", \~IlK,,1 HI!ll S "')I~' (' "" ,,{,../ lIl' l,(: ,\ci "in­i«'" i,u.,rfw"> dec JIi'~ J l u,i." 'c~,cr ,,';,h 'he I II' I..C "'''' '' ' ' " ' 11'0 ""Ill ,,~~h ,b , j 1, ,,;,.,,1<,,, 1'''''1 ' S, ml'k Col""", ,,1<1 '" 1,,;':""'­,\ hlu lc c',,,,,i-'(ing "I' , RI,,-,.Iynt " h" ,", j , ')'-;"~, 1" 1111'_

IIl.Setting Measurement Conditions '1'1", ""Ii l i,,,,, ,~' "" __ " ",t",,-,,t i, ,,,,,10 ~:lll l"'mt" re, d.>ic"t d

1\lt'",I"" ", ,n" r\'''~P ' '', , li d ,be t i' Ill"~ "I "'111 1''' ,dl", i,,,,, rh,,,, ,Iq~:" d '" th " 'yp" .,f 1'"",1,,,,,_ ,\ I,h lYl'g-D ", ... , ,,,II"' '' tJC<.>t, 1" ' 0 been '1~'ie.1 to, Vlri'ty ,~' p".IU<1s i,,, ' lill i lc~ th " J ,i'I):" po-ut, ,,'J! ClIL " (,-", ,, ,'-'.I,k (" "1)' "" " '~'xl.

A_ T"",I" ""( u", R""'lx<>r [" 111 " "1.1'."', i< get)('l', II , I< l to Jc'C ,'-' ' I'W,-,i"",'" ,lm

;>ltf""c ""'I""",,n-,?,j ,-\" iIlCR'''' ,n ''''''I"'o,I.1l11'( ",,,,,1,1 rc ... dt ill on i,,,"',",,,, U\ ri co " ,hI< "tc', "'-' ~" '" ,h tl';"" h ", Je' (c,r " ;7"J ""gh, ['" rhtifi,h lc. ' 0 1 JI1 ,h " ot her h ,,~I , "" c"""';"') 1,, ~1t '~ " 'I" '_ "u Il' tI"t ~'''u I ,I ",d, , I"" I"" or ,,'h """ ' ~ ' '" ,,', "g>' i "e< '" po,' <i , " I , h",ii'" ~lx<J I,II", " ',,,I c'd, I" '""" C""~" ];1" " ",,,) ~", Id ,hid, "n , ~nf.'k ' ''"1'' ''''"'< ,," ,ltH " fn , .11 ,,( , h"i , rek"" 't"I ,,~

B. ,\ Io",b,'",< "nJ '-=1"'" Tl~, mflll l"'ll (' ' od r,c"i~'" """,1,1 ~" "" :1 l h' Ix """ ,,Icr,,1

''1'c',hcr, ( Ill" " """ " t I>c ,",,,I ,, ~ ">:1'1 "" 1l,Ii ()' j"t " " ,"", rI ,,' t W,", !" ,d,lit;';'" ri ll' ,,, ,,,, 01 ,",, '" ",,-,1m "b", ",,"" lfC I'" '''' " . 1 'm l~l", '''~'I*'' ,l "i d, \\,1*" dll~",d\ I"",," ,,,, I'''' "i ,he """,, ],"":.;, Dn'g ,11", ,t",,,",,,., ,1l ",uVI, the' ",'" , , ~ . li , 1 ", ,I" ",emhcm, ~,r&;-" "",1 then thrl"'f h rI", l'I" ,d III:, J I""'" ~ ' lh i" Li re' "",,,1,,,,,,-, ""lore ""d"n~ th.c 1",1, .,1' lh, ''''-'1'"''. wh"" ""'pii ng ''''''' ,''

I IIf«I',..lwidl<J.", ' I"'" "",,,pi,,, , ,, II ,,,, ri Le ,Inog " 'i,I ,,,,,, Ii" ,;, " '~ ;t> """l" n. ,nd

'''"\1, lh"rdi~c, e,h;l", tiI,,1 ~Jk"l1[ I "'pen",~ ' " "" "". i" <ilLk con-

ditiolls. Drug .;;ol uhiliry should be a minimulll of ten timc:-. dH.~

highest expected concentration within the n:ceptor. J\ latching the receptor to the extern;1 1 phase of the scmi!:!olid, where possible. lim­iL'i sol \'ent diffusion. So doc!:! choosing;l receptor that is completely illlllli-;cihic wi th the 'icmi'iol itl 's exte rn,ll ph:1'iC. The analysis is most conveniently ,lccolll pli 'lhed hy direct use of the n.:ct.:pto r. e.g., h} injeC1'ion onto ,Ill II PLC l'Olullln. The desire 1'01':1 convenient ana­

lytical procedure mar influence the choice of rcceptor. In addi tion , the receptor sholiid be a highly fluid (noll-vi-;cOIIS) I1werial for n:a­'ions that arc explained helow.

!. ,\ 1l'lJIhrtlJll' jilJlc/ioll.l·

Thc mcmimll1c prO\ide'i ph}' .. ical 'iuppon tu m:lim;lin :1 COllst;lnt contact edge with the ')e llli 'iol id ,md prevelll hulk transfer. It llIily he possible LO work with rigid semisolids wi thout using ;1 I11CI11-iJr<mc. The 1ll ell1hr~1IH.: shou ld be inert toward hoth ('he receptor and the semisolid. Potential Illcmimllles Cil ll he scn;clled for drug binding hy passing a n.:ccptor liquid cont'lining a low dl1lg conccll­trat ion, com para hie 10 th;lI \\ 11 ic11 will he encounrered ill dlC

experiment, th rough the l11clll l>r;l l1e :In<l :ls..,:lying thc lillr;Jtt: to \'cr­ifr that no loss occurs.

Perfect wetti ng of ,he Illclllhnllle br thc receptor iii necessary to

ensure that air within the pores h;15 hcen replaced cOlilpletely hy liq uid. A guide \(J the su rt;lce clur;lCter of thc lIlelllhrane m,lteri:ll

-, -

is a pJramercr c:t1led the critiGl1 surElce tel1siol1. If the surface tell­sion of the liquid (receptor) is equal to or less than the critiGl1 'iurEtec tension of the memhrane surElcc .. the tont:1C( angle is lero and \\etting is perfec t. CritiGll surElce tensi,on ra lues for JlIan~ ' lillh

'it,llteeS may be fot Lnd in standard referencc .... " I I f the mcmlJr.lne n():lr when it is thro\\n into :1 beaker of receptor, \\elling is poor. Ilowe\ er, the converse b not netess;lrily true; a sin king mel11hrane docs no t,

in itself, b'1l~lr:lI1tec perfect wetting. 3. ,\/em/Jrnlf(' rcsi.l-ffln{'{' to permefftion

In il release expcrimcnt, drug migr:ltion from semisolid to rccepto occurs as a series of "'lIcte'lsive diO'lIsion;ll 'itCps. Since the ph)''iic properti cs of the product iLseif ,Ire of interest in th i'l llIeaSll relllcn diffll'iion through the 'ie llli50lid must be the r~llc limiting step. It i'l therefore, important that lhe lllelllbr,lIlc and receptor he highly per­meahle to the drug.

r

11 t,

The membr:ll1e, LOg-et her with ,Ill unstirred layer ;11 its surf:lcr.::, offers linite resistallce to diffll~ion. The effect of this resist:lIlce Oil the sensiti\,jty of the release test to \'ariation in sevenll par3l1leter'i \\ ,1"0

recently explon:d.32 Simulated rclea~e d:lt:1 \\ere gencrated using a the()reticill equation that took mcmbrane re,i..,l:IIlCC tt) pennc,ltion into ,ICCOUnr. RC:l lion;lhic \;l llleS for dll.lJ,{ (oncenrr<l1iOIl (10 mg/ml), solubi lity (0.2 gill/ill I) :mel diffusioll coell'iciellt (I \: 1O-() cIll2;.;) wcn: ~ l ssu !ll cd and different v:ducs for memhrane pe nlle ~lhilit)' were mod­eled. T he intrin :-.ic release (release fully independcnt of the mel11brane) \\,IS the ~tand;1rd for comp;Jrison. \ Vith rdati\'ely high val ucs of memhrane pcrmeabi lity, thc 'i lope of the release plot (allloum released ""t. (he square root of rimc) ";1 ... e'i'iemi:lli r [he .\i,IIlt(; :1"0 the intrinsic rcie:l'ic 'ilope. At lowe.:r val ues of membrane penne­:I hility, the relcase slopc heca me sign iticantly 'imalk r ,lIld thc intercepr with the abscissa, l;lrger.

014~ • 3.00E-4 I

0.12

'" • 1.00E-4 a. 0 0.1 - • 3.00E-5 iii 0; 00. !. .J~ • INT

E 006 V,.. I

'" E I ~

" 0.04 •

I

.5 0 .02 I

~ 0

o 5 10 15 20 25

Time (h) F;gfll'e 5. 5;illlll/(/tl'd dlfftl.l'bo7rillf!, rate 0)'/,1'1('(/,1"1' 11.1' a ji,I/(f;OI/ of

flIIIJ'.!;)!· <."ar;()II.1" 1111'111111'11111' PI'I'/IIl,(/f,;!ity (Oejji(;l'lIt ;,,(tlm'.i·. ,\lode/ P(/I'(/lII{'/t'I)' (/rt' 11m.\"(' IIt;!i:.n/ ;1/ n:/;'rt'lIn' ;2.

The tomrihution of lhe IIlCmhr:lI1e to (ht: relca ... e profi le is greater initially th:lll ,1her 'Ol11C time ha::. clap,t:d. O,er lime,;1 diffusional hlyer th;11 dC\'dops \\ ithin the ,emi'iolid hecome!:! rate controlling. Fig. 5 ~h(J\\s h(m the slope ch:mges incremcilu lly mer time. Slope.: \'aluc~ incrca~e \\'ith time, ;lppro:H.:h ill g:1 pbrc:lu v;lluc. 'f he greater the mem­hrane pCrTne;lhiliry coefficient, the shoner the time needed to reach lhc pl:Hl'ali. :\ practical consequence of this p:lt lcrn i'l that c;lrly time point.., In;J ~' h;I\'c H) I)c ncglected in c;licu la(ing [he releasc II 'II ope.:.

\ 10" memhranc penne:lhility al'io hlunrs the scn"i ti \- I ity of tht: rdease 1IH.::;lsurelllcnt to changes ill imponallt P'If<lllll'ters. Figure () ,ho\\s the dTcct of challge~ in the

fJ issO/llfioll7i'(/lll%gies/ FEB R U A RY 1998

In Vitro Release from Semisolids ... continued diffll~ion coeffkimt \\ ithill tht.: semisol id (I)) ;lIld I~ the PCflllC:lhiliry coeffIcient of the 1llt!mhr;lIle/~tagn;lJlt byer 011 the rele;I ~t' slop!.:. ,\11 illcrca\c in D of 50% n: <.;lll l ') in ;I ll inCl"c:bc in the rele:lsc 'ilopc of ;lppruxil1lareiy 11%, provided that the IlH:mhranc pcnncahilit} \\ :1\

high. \\11cn it h,1(I ;1 1)111:111 \',llue, the ch:lIlgc ill slope \\a\lllm:h ]e"".

w

" • IN TRIN SIC Z ... :r

E! 3 E-4 U

II: ~ lE·4 w ....

w 0 "

3E-5 ... II: ... CHANGE "-

• 0 - 4 0 - 20 0 20 40

PERCENT SLOPE CHANGE Figure 6. P.jJi·Cl OfpI'I"IUr/lfffioll 0/1<:'0 l1ttrfllll l' /I' 1"S • . ft'misolid "U)i/­

sial/ (D(j]ieil'lll (J) tllltlllll'lIIhnlllt' PI'1""('ff"i"~l' /"O/j)im'lII (P) 011

n 's/JO/N' oIri'/nm' IIII'flJllrt'IJII'lJI.r . .':;illlff/lfli'd dllllf jhull n1~" "/'JJ(l' ;:!.

Release :-. Iopt.: :-.hould thenrclicllir he lIll:lfb:tcd hy ch'lIl g-es in the mt:mbr;lIlt:. Th i" i ... only true when lll elllhr;lIl ~ penneahi lil} i~ I'eb­tin:ly high (Fig. 6). Furt he rmore, when there :ll'e I.:h:111 ges in both D and P, the re~ponsc is domi1l:ltcd hy sh irl'i in E Figure 6 shows th:1t the membrane permeahility detel1llinc ... the extent and direction of the change in slope \\ hen IJ is ra ised b~ 50/X, :111<1 P is simultllleou..,­Iy decre:lsed hy 50%. \ " hell P is high to hegin \\ ith, the ch;lIlge in ... Iope prinuril} rdlcl'ts the I.: hange in I) , :1 property of thr.: ;,;emisolid. \ \'hen the melllbrane p~rrlleahility is slll:1 ll, the t hange in I) b large­ly ignored :mel the slop~ d t:l.:r~ases in \';l lue, dt:!ipitt: the f:Kt tklt D h:l'i Iwr.:n r:lised.

elc,ldy, it i~ dc ... irahle to keep the lTlemhr:lIle penne:lhiliry as high ;I.., po ... si hle. S()me gu idalKc in ;ltuining lh i ... g(lal Gi ll he oht;linc(1 from e(\lI:lti(lIl 3, \\h ich dcllnes the meJllhnlne penlle;l\li lir}' c(leftkiellt, E

I' = D\[ K<ll/Th (Eq. J) In this equation, D.\1 is the diffusioll codticient \\ithin the melll­

hr:me, K the 11leJllhr:lIld~e1llisolid p:lrtition cncffici r.: nt, <I) the memhrane porosity. 1 the memhr:llle torruosi ty and h Ihe Illelllhr;lllc thickness. Olle gO:11 in membrane/receptor ... election is to maximize the product D" K<t> ;mel minimize Th. Therefore, the Illembr:mc ... hould be thin :md highly porou~ (to make h !.1ll:l ll and <I> brgc. n.:specti\'d y). T he receptor, \\ hich till s the pore ... , 'ihould he highly l1uid and have ,I high drug soluhility (to 1ll:lximi/.c D.'1 ;llld 1-:., respec­tildy) .

.J. IV]rct of tbe rt'ceptor 011 retcII,I"!' .Ilope [dca lly, the receptor should :let :IS:1I1 inert si nk to co llect drug as it

diffuse~ from a <iemisol id . Theofl!tic:llly. then, I.:hanging the colllpo~i-tion of tIlt.: rel.:q Hor should ha\'c no dTetl on relcase :1 ...

I long as both reccJltor~ maintl in ... ink condi tions. Thi ... i"

I not :lh\ :lys ohsencd in pf<lCticc, The rco.:ptor Illay JIlodi­~. the release rate hy contribu ti ng to :1 diffu..,iomil resista ll tr.: (:l'i dC'ilTihed in the pre\iolls sCl.:tion). Sccond-

/)is.l"o/lf t iOIl'/edlll%gie.dFEB R UA RY 1 <)<)H

Iy. b:Jck diffusion of the receptor I~light :l lter drug solubility in the ,cmi ... olid. In:lll extrellle eX:111lple,3 .

, oeranol diffu'ied from the rel.:ep-

101' into a crealll, dissoking it I.:olll plerely . . \tternpts to :t<iS,IY the "emi ... olid for slll;111 ;lJlloullI ... of receptor are likely to he frui tless. \dditiollall~', ;ICCUIllUl:uioll of c\'en 10\\ COllrelHr:l tions of ;1 good drug 'inl\ r.:llt in the imcrElI.:ial region i ... likely to have <l di'Jpl'Oportion;llly larg~ effect 0 11 rdea"e.

200 ~

~ c. 0 O .. leonlUole 0

0 U; 150 0 Triamelnolone Aeelonide

~ w ~ 100 00 ~ .. 0 0 II:

50 2 0 4 0 60 80 1 00 1 20

% Ethanol

I'~!!,III'I' :-. h,'j]i'(/ ({dWlIgl'.I· ill l'lbllllOI m llCl'lI/ratioll on IIIt'fI.I'II1W/

rdl'llw' .flopt' f or /.:' 0 .~l'.I·I(·III,f. II I~ )'tlrol/kobolil' g el (on/I/illiug I'rimnri-

1/0101/1' (/I"t,touide 111/{1 " In'fllll (QJI/l/iJliug oxi{(JlIII':,oh' IIiI'm!!',

Figure 7 show ... the effect of eth:lIlol concentration in the receptor 011 relea~e of t\\'o drugs frol1l t\\O very different systems. Tri:llll l.:i-1I()lolI~ \\;IS dissul\'(:d in :1 si mple ~el while oxicon:lZule nitr;ne was ",u'"'pended in :l tfeilm 1I;I ... e, In hoth cases, raising the ethallol COIKcn­tration J"C"ult~ in all increa'Jc in rele:lse slope. J IO\\/:\I;'r the eh;lIlge in o\it'CIll:lzo le relc;ls(' i ... Inlll:h larger, perhaps renecting rhe impoJ1:lnce or dissolution of ~oJlle of this drug \ ia b,lck diffusion of t!thanol.

In ;1I1other draJllatic exalilple, \'arious hydro:lkoholic solutions \\ ere jlwestigmed :1-; rccr.:ptors to swtiy release of bct:lI11crhasone dipropion;lte from two !.:reams \\ hich dilTered ill tolllposi tion. ,q The Ie ...... potent product \\:1 ... reka ... t:d Illore r:lpidly into 6WXl eth:lIlol, but the order \\;1, rC\Trsed into JO% ethanol. .\s ill Ih t: examples showll ahme, :111 increlse in ethanol I.:Ontem in the receptOr produced :lll incre:l"e in release slope. The effect of the dilTen:nl.:e in receptor ethanol conteJ1[ on the pruduct containing' su ... penJed drug was sig­nitil':uuly greater th,1I1 the othcr crcam, For the tfe;1111 containing ~u"'IH.: nd ed drug (le'i~ porelll) the r;ltio or reie:lse ... Iope.." 6WXl ethanol receptor:30% eth ,l11 ol reteplOl', \I':IS 3.8; the correspond ing ratio for the l'J'C~11lI contilining largel~ dis~nked drug was 1.4.

From these eX:llllple\ it i" :Ipp:lrcnl th:n the release profile ciln be n1:lrkedl~ influenced h} the choil'e of receptor fluid. Comparisons of (Iifferellt forl11ulation,", 111\1"t he in terpreted \\ ilh c;lutioll. \ ':l lida tion ~IUJie" :lre required 10 cOIlGrlll the uti lit) of :1I1}' release protocol. C. 'Timing issues

\ s \1 ':J'i stated in the pre\iou~ sect ion, the e:lrl)' time va lues of :lllJOlJllt rele:lsed Jll:I~' not represent the siw:ltion ill whil'h diffusion through the semisolid is rate controlling. It nuy therefore be ncecs­'i:lr~ to ignore olle or 11Iore da ta points ;11 the heginning of the e.\pt:rilllc lll ;lnd lhC the remain ing \'allles to obtain the rele:1'ie slope. This ... ituation is illu"tr;ltcd in Fih'l.lrc 8, line 2.

Line I in Figure 8 exhihits ctlnatllre at hlrger \'alue'! of the square ront of lime. Th is pattern is :l1ltil'ipated Ilhen drug rele;I'!e exceeds

Figure S .. llIliaplll l'd reIN/)"/' {I(ff/tTII.\· jiW (11'0 .~·fJ·'I'IIIJ. I, jilJ/­

n,Jt'II.l"illg gel; 2, JI01z·- reh'fl.HIlP: Q;III111I'III.

approximately H-45(X. of the scmisolid's initial ttlllll:nt. At thi::. pOilll, dlc a~sulllpti()n:-, undcrlying the t' l]ll ,ltions \\hi(h su pport a line;lr n:b­lion hetween amount n..:k:a~ed and thc S{luare roOt of lime an.' no longer I';llid. If rele;l'ie i~ llllitc rapid (e.g., dis~ol\l:d lOll molecular "eight drugs ill gd \Y\IClm) Clll\',ltllre Illa~' he Cllcolllltt.: rcd in lc.'i~

than thrce hour~. -r'hert' is tlllI~ ,} rimc II indo\\ during II hich relc:l'ie cxperiment\

~holl id be performed. Dat,l shou ld be collccLcd at til1le~ .lfler the influ­ence of memhrane ,11ld it~ associated sl-agn:lI11 laycr disappe:lI'~ but before cxcessi\'{: drug depletion from the scmi'io lid ()ccur~. Beclllse of significant diffcrcnce~ in release patterns for dis'iolved \'~. ~uspended

drug~ and crealllS or gels "'i. ointments, it is proh~lhly not possihle 10

<b'CIop <l single prow(:olth:u applies to all \elllisolid products.

IV. Applications - Method Validation The core of validation of an jfl-l'itru relea'ic 1l11:lilOd i~ tht: ,lbilin to

detect <.: h:l11 ges in the n..:lc:lsc ~ Iope rh;lt occur when IC>n llubrioll com­position is changcd (:1t.:tive ingn.:dient concentration , cxci picnr composition and amount), whc.-:n hatches or 'OllI'CeS of ingrediclH.'! ;He dunged, or when method of lIlanufacture is (hanged. As noted ;11101"{;,

the logical par<l111etcr for c(Jll lpari ng release Chal~l{:{cri~tics is the sl()11C

of the lin c;U' ponion of the :1I110UIlt released , .... "quare root of timc plot. Some recent ex,lIllples of studies which \holl a rcbtion ... hip hetween the release 'ilopc and product or method variables will I1ml Ile sum marized.

t\ 19H9 srudv of lhe rcle;lse of l1\'drocortisone frul11 cream'> ust:d Frallz diffusion' cel ls and ;1 variety 0/: synthetic lllCllIhral1l:s!l. Relea'le profjlc~ were comp,lrcd h~ ' calcul:lting steady 'itate flux r:He ... (pgkm2/h r) from the line:lr porrion (Ia.-,( th ree d:ua poin t") of the clllllul;l[il'l! alllount rdea'ied per unit :lrea \'\. time cun es. In experi­ments with r\\'o hr:lnd~ or ('rC:lm, for;1 gi\en limlllliation, nux \:llllc~ were not sign ificantly difTen.:nt reg:l rdl e~s of the melllbr:lne lll;lteri:ll (polysulfone. pure ce llu lose acet;ltc, ce llulose with wctting agent, :lIld triton free cel1ulo~e), except iilr slightly slol\er nux \'.llues II"hen a glass fiher filter W;lS uscd. \Vhen the two hrands ofcre:l11l were tested under ~iJll i l a r conditions, the nux I' alllc~ Ilere liHlnd to Ilc ~igllifi c:lnr­I)' diffcrent. \ \ In.:n diffe rent hatches or £Ill: \ame hrand II erc compared, relca"c protllcs were found lO he n:ry reproduciblc for both hr;lIlds with no 'iignillcanr ditferencc~ in tlux \,'llues. In a suhsc­lluent comlllunication1'i, it was propo~ed that "filr thc purpose of:l

h;ltch-to-hatch test, or:l (Omp;ui!)oll he\'l\een innov;1tor ;l1ld generic products, the slope\ (o f the ;Hlloullt released per unit area I~. square rool of lime plots) would he meaningful and aCl.:UlillC, and would JI1:tlc cffil.:icm usc of :111 the cxperimelH;llIy coll el..'tcd data." T his cOlllmcllt:lT") :!lso cautioned ag:li n~t CXlT:lpolation of rcsllll~ of these in r.'itro experiment .. to [he IJ/ t'it'u sinl:ltioll. In /99 1, the methudology developed for hydrocortisone cre;IITlS 11' ;l'i applied to determine rcle:lse from lotinn ... :lIlt! Ointill em~.P. In order 10 ohtain detectable len.'l ... of h~ 'droconis()lH: in the receptor medium from {he ointl11elll fonnubriol1\, it 11;1\ llt!cc:-. ... ,lJ}' to pre-treat a hydrophilic memurane kellulose ;ll:cr:lte) 1\ ith i\opropyl m~Tist.lte to imparl mixed hydrophilic and lipophi li ( propert ies to the memhrane and rhus enlunc(,' rdea~e of hydrocorri\ont: from the oimrnent. The sUldy found ~illlibr rde'l:-.e ~I{)pes from cream and lotion bur sig-nificantlr lo\\'er r(,'le;lse ~Iope from {he ointlllcnt, which reflects the influence of the \'i'icosity on the diffmioll cocfflcicnt of the drug hetween the I'ehi­cle :mel the receptor ph:tsc. The authors pointed out thar the ph:lnll;lCological re\ponsc i\ aCllIall~ grc;ut' r from the ointment due 10 development of ... lin hydra tion, and cautioned Ll1:Il "rc!case cha rac­tcri\tic ... should not he compared :lcro~~ types of r0I111ulation~, such as crC;lJns, ()intlllclH~ and lotions. All comparisoll\ should he done only lI'ith 'iimibr formui:ltions."

A colllp:lrison {)f rhe rek:lsc behavior of trierhanolarninc sa licrlme from cOlllmon ly used ointment h:lses with variolls additives (pcnctra­lioll enh;mccrs), and frolll two cOllllllercial products, used a modified Frallz ('el l :lpparatll ... l6. T hesc studies showed signilic lIltly higher rcle,lse from thc eXJlcri lnental fonnulaticlns dun from the colllmercial liJrlllUhllions. :\PP;lrent ,iscosity profiles of thc formulations were ohtained but showed no cblr correbdon with drug release.

An cI:l lu <ltion of {he n.:lcase uf griseofulvin 1'1'0111 gels used Pranz diffusion ce lh, li. Significant difli:rence~ in reit::lse ~ I opcs wert:: found :llllong gels prepared using- different solvenrs and different drug con­ccntr:Hioll<;, with differencc~ in release slopc~ dircctly proportional to

difrercnce~ in drug concelllratiollS for a gi,cn gel fonnuhltion. In 1(1)1, in l'itro rc!ehc of hctaJllcthasone valera te from two brand'i

of cream W,lS measured using Franz cclls and l.:Olllp:lrcd to in i'h·n skin hlanching ch'lr;lcteri .. ril.:s HI. It lIas found {hat the reie,lsc slope was 'ii",nificllltly greater from the higher bhlnching liJrlllui:ltion, hut the author'i G1LllinneJ th;1t while "the correLllion ohtained between rhe ill 611'0 rclc:he :lIld hI 'i.·i;:o performance adds 'itrength and valid ity to the ill ;"111'0 tC~I...it ~hou ld he emphasized that the rcblse lest is stricdy a lJu:llity control test [() :l~ ... ure Int-w-Iot uniformity :ll1d should not he u\cd to predin hio'll.:til it)."

,\n ill i'ltro re!el\C mcthod for rt.:!tinoic acid cn.:ams llsing' modified FnlJl7 ('cll ... W:lS de\'Cloped :1I1d validated w. Fonnubtio~ phys ico­chemicll f;lcwr~ (drug (Oncentration , internal ph;lse droplet sizc distrihution, I' ismsity, ,1I1d l.:Omposition of clllubion intcrnal and c\1l:rnal phase ... ) \\cre varied and comp,lred for inlluence 011 drug rdca:.e from crealll~. \ 'iscosit~ mC;ISllrcmcnr~ IIcre also ohta ined hut sh()II cd no mrrclation \\ ith relc:he slopc~. The Illl.'thod \I;} 'i ... hfl\\n to he 'iCllsiti\'e to formulation dunges. with oil ph<l\e vo lume r,Hin ~h()wi ng the mo:-;t :-;igniflcam effcl.:t on drug rdcasl' slope. Intcr- and intr<l-

/)i.(>'O/II/ iOIl,{h/",%gi('.dFEIl R UA RY I ~98

In Vitro Release from Semisolids ... continued batch \ariation \\;1\ found to be low \\ illl n.:ry rcproducihk APPENDLX - Equipment Suppliers rele;lse slopes.

All ill 'vitro relc,lsc method for ten:on:lzo1c crealll fortnul:uiom using moditled Fril llz cd b was dC\'l.~lopcd and \'alid:llcd'W . The method \\;1S able to detect differences in drug IO:Hling, drug particle size. and formulating tCl:hniquc. Relea.,c profiles were: oht;lincd for ek'!ven lot~ of the cOlllmercial ere,11ll product. and lot-to-lot \'ariabili­ry \\;1S liHllld to be low.

Diffu.,io ll ofhydroconi.,onc from;1 cOllll1H::rci al ointment formula­tion u., lIlg Fralll. diffusion cells ;lIld \'an KeI Enhancer (immer"iol1-di <;soI LHioll type) cells was Ill c:lslIn.:d and comp;lrcd H. The authors reporred higher Clllllubti\'c n::lc:l'iC ;l~ wdl :1'1 gn~;llcr

dur;lbility ;mel eaSL: of u')e {()r the Enh;lncL:r ecll vs. the Franz cell. 1100\e\'cr, the datl were prescnrcd as plots of cumulative amount rele,lsed \ "i. timc, and the "tll llluiarin .. ·' amount rele;J ')cd oftt.:n :lCrual ­I~' decrc;l"icd from one tilllC p()int to the Ilcxt, No slope C<l kllhlt iul1~ or othcr 1ll:llhcm:l tic:l1 trcatment of thL: datI \\efC presented ;lI1d the cO llclll ~ioll S were drawil solei), h;ISCU on the ViSU;ll appc.lrallce of the ;1I11UU I1l n.:Il!;J~cd \·s. lime plop"

AI10lher srud ~' comp,lred release prolilcs from gels of differing con­ccntration ... of trbnu:inolonc ;ll:t:tonidc u~ in~ Fr:lll'f. ditfusi()Il (ell~ all ,1 dissollllion cc ll s·lI . In the..,c c'\pL: rimcnt'l th~ rde,lse \\as found to be rapid ;lI1d linc;l r with sqll:m.: root of tilllC, with rdc:lsc slopL:s \'arying in dircct proportion to drug cOllcemr:uion in the gels, \ Vhilc bOlh types 1)1' apparatus pn)<iuccd similar rc..,ult'i, relc:lse slopes \\ cre !-' Iight­Iy highcr and diffll ~jon cocfticienrs morc consistcll( \\jlh rhe dissolution celk The ~rud i es also showcd ;J decrease in n . .:1c:1..,C ~ Iope proponionallO:111 illCre:lSl! illl11cl11iJran l! thickness.

In IlH::l.,uring ;Jl i.'llrO relea'it' of hel:11l1 l:thas()llc dipropion:Hc from petrolarulil oinn11emS usi ng Fram cell s-l2 it \\;lS possihle ro dj.·,tin­gu i.., h hel\\ eC Il two di fferent fonnul:lt ion.., cont1ining the ..,alllc coll ((~ rllra tion of thc drug. ,\I ethods used to oht,lin dctecl:lhle, i.IU :lI1-tifiahlc k\cls of drug ill thc receptor medium were :IISt) in \'l:~ligated.

R ell!:l ~C of phenol from lletrolatul11 ointlllent s was :-.Illdied using­rhe dis'Jolut ion cell system;). Rele:l "ic Ch:l r.lcterbti(s \\ere: c()lllp:l re~1 to c\'a lua tc sensitj\'ity or the method to ch:mge~ in le ... t panlJlleter ... (~ti rring speed, IllCmhrallC type), formulatioll (:lClin .. ingredient and excipiemlc"cls), and m;lI11rfacturing procedure, :lIld to idemil}' :t cur­relation hr.:rwccn drug release :lIld ointment rheolob')', Relcase slopes were ..,llOw l1 to be the ..,ame whether di ffu sion \\:JS lhrough a n~ ' lon

mernbr.mc, a cd lulose acel.lIe Illcrnhnmc. or no mt'lIl hr:lIle :11 :Ill; hO\le\'er, ~t:lIl{brd dc"iatiom \\ en: gre:llly reduced \\ hen :1 rnembr:mc wa~ u:,t:d, /\L \:lrioLl~ ~tirTill g spccds (75, [2 5, :lIlt! 200 rpm), rL: l ea~e

slupr.:s \\lTe shown to be the same; ho\\'e\,l'r. "iland:ml de"i:Hioll>; \\ere significan tly grea ter;lt is rpm. Relea ... e 'i lopes \';Iried proportionately with drug COllccl1tnuioll :md changed signilic<l lHly \\ hen c\ci pient lc\'cI~ and method of m:lI11rElcturc were \·:Iried. Preliminary rheolog­ie ch:lnH.:teri z:nion suggest cd ;1 possihle t:orrc lation ht:tween rde:lse

beha\'ior :111<1 cL: rtain "iscocl:l..,11t: p:1ra11leter~, In gencr:ll,

as the oi ntment \'i'it:osity or magnitude of the \iscom component of the ,iscoela..,tit llI:ltcri:ll (,, 10-.. .., tangem") increased, relc:1..,c -;lope corrcsl)ondingl)' dccrc:I..,ed.

Oi.'so!1I1 iOIl Ti:dlllo!ogics/ FEB R U A RY I '}'}H

Crown Glass Company, Inc. 990 I':\ crgreen Dri\ e SOlllcrl ille, N,I OH876 ('>08) 526·3 115 I-Ianson Rcscarch Corporation IJH [0 V;uid A\'enue Ch:lI"lOrth CA C) I J II (800) 811·8 165 VanKcI Technology Group 1.;000 \ \btoll Park" aI' Can NC 275 [3-222H' (SOli) 229·1108

References

\-Va ters Corporation H i\ bple Sireel ,\Iilford .\IA 1l 17S? (508) m·10IlO Pcmlcgcaf PO Bo.\' 241 • 1007 Easton Road Ricgclsl ille, I'll 18077 (6 10) 74')·2092

I. 'J,I-\, P:ttd and 'J. F. Fo~~, '; lntcr:1ctinn nfSulllc Plurm.lccutica ls \Iith \blTonHllende., I,"]. PIJi/I"IIl. S'a. 53,9-1- (1964).

2. H..f. Poul'lcl1, E. ' ()\1I1~, \ '. C:ulluill:l, :lnd ,\\. KOlti',,"Fffect of T()picll \ 'chick- C:llm po'litioll uilihe III / 'ilro R l: l c:l~e of F[ u<x:inollllle .t\cetollidc .md 11~ \cCl,ll~ E~ter," 7- I'blll'lll. ,)I:i. 57, 92~-tJ3 ~ (19M").

~. E Bill up .. ;md ~! : K . ]l;nd, "E.\llCrimcm.., in Ph~'siC:1 1 PIl;I r1 llaey. \: In \ 'itro Relt':;hc or .\lcdicl1llent From Oim1llel1t B:l~e'-,," ./111.]. I'hlll7Jf11{fllliml F.dIlCrlflllll, H , t t)()-l ()6 (11)70).

4.,1. ()..,trcng;I,J. II :llch1i:l ll. B. Pnll[ ~cn, B. Ferrdl,:oJ. j\\ud [cr. :md S. Sh:l'ltri, '; \ 'L:hidc [) c..,i~n for:l Kc\\ ' [()piCl1 Siertlid, Fluocinonide,·']. Im.'I'.(IIl!II/{'·I' /)1'l7l1flfO/O,f.{l' 56, W2-39<) (1971).

i E Bott.lri, C. DcCulo, F. i\':m ni pieri , \I.E S.lcllont:. and \I.E Scnlfinl. "Influence of Drug- Cuncentr;lllllll on III l 'ir,-o Rclc:l..,e of S.l li~ lic \Cll[ from Oinrmcm B:l'.,c\"]. I'bfll'lII . • )'0. 63 , 1779- t i8J (11)74),

6. I.T. Ch()\\Il;lI1 :lIlt! R. Prilch:ml, "Rcb~e tJfC()rtiUlid~ frolll ()1e;I!-!,illou~ Oimmellt B:l'1e't CUlll:1ining [)rug- in Su,!,pell..,ion."]. Pbflrlll. Sa. 64. ;0;;+-7)t) (1t)75 ).

- . K. Ig;l, \ . I hl'1..,;lm, .md T K;I~h lh :lr,l, "Hfect ofCol1lplc\ FOrlmoon het\1 een 4-1 1c .\~ [re~orcillo1 ,lIld Etll) I ,\ I) ri~t.ltc Oil Rde:l'-,e Rue of 4-11c'\~ h~nrcinol from PdroLl1lll11 13:1<.,e."]' 1'11fI17II. Sri. 70, 9W-943 (1981)

H. R.J. Bchme, TT KL:ll'>ler, ;md D. Brooke, U:\ .'Je\\ Technique for Deterlnining III I i'lrQ Rde:l.,e R:nL:'" tJf 1)ru!-!"~ From CrC:lI11'-,,"]. Pbfll"lII. 5;(/. 71, I HIl·1 'IIi ( I'!Hl).

I) , \\. Ot.lgiri. T FUJIIl.lg;l. \. S.lLl i, .1Ild h.. l 'ckJm;l, "Fffc(,h of ~- ,1Ild y-( : \dt)(le\lri n~ on Relc,l ~e of Bet,ll1ltthNlIle from ()in llllen t B;l'>(:"'," (;lwl1I

PbllJ'lII. nflli. 32 , 24()1-24()~ (1984). 10. 'J. \. \rm~lrong. [1..\. (;riftiLll ..,. :md ".C.j;lme'>, ",\n III/ 'itro

,\I!llk[ 10 SilllULlIc Drug Rdc:N.' from Oi[r .\Ielli:l,"'m.]. Plwl"lII. 41,115-II '! I I'!HH).

11. J I ~ Skdl~. \ '.P. Sh.lh, I 1.1. \\;Jiluch, R.I I. (;uy, R.C. \\ 'c'Iter. G, FI~1l1l,

;lm[ \. Y:leohl, "FD \ ,mil \ ,\PS Repnn of the \\'orbhop nn Princip[e .. and Pr:ll'Ill'e~ tlf III Iitro PC1'Cllt:HlCOll!> Pcnctr:lIion Sllldic~: Reb;mcc ttl Bill:l\;lil:Jhility.mel Hi oelllli\,:l[cnce," I'htll'lII. ReI'. 4. ]65-]67 (1IJK7).

11. 11.1..(;.,\1. Tiellle~'Iell, I1.F. Budd.l, C. \;lIl ,\Jollrik, :md I I.E. J UIl~in~er. "III , '/tro I) rllg Rdc;]~c frul11 l ,i1luld CI~n(;l lline ( :re:l llb; Cream Structure Dcpemlence," !'row: CollolIl'::''' !'o/1'1I!fr Sa. 77, I .~ I· 1 .~:i (198H).

Ii. B. ,\bnin, 0. \\'.lm, H. Shrout, ;mdJ,C.j;lInoullc, "A 'JC\\ Diffu O,IOll Cc1I- ;lIl.\UlOllWICd ,\I cthod for .\lc:l'lunng the Pharll1:lCcuticlI \\ ;lil:lhi1it~ of'lifpiC:l[ DO'ilgc Forlll~," 1111.]. Pbmw. 49, 6)-6H (l9H9).

Ii. 1.. 'Jiellli .md P. K;lhL:Li, "Effect of \\'ater Content ,lIld " )'Jlc of Flllulg;l1or on rhe Rdc;l..,e of ' I ~drucon i,>onc from 0 /\ \' CreJm..,." . l ffll

pt.r/rlll. \ (11"111<11 l. 21-;0, ([t)~t)), to;;. S.(:. C:hi ;llll[ 11 ,\\' . .IUll, "Relc:l~e Itlte., tJf l-\clOprofell from

PolO\mncr Cc1~ in a .\lcrnbrandt~s Diffu!> ion Cell,"]' PbllrlJl .. )·(1.80, 1HO­!SJ (1991).

16. I\\'K. Youssef, I~. I ·:. Zein EI-Din ,1I1d :\\...\ . Fouda , "PrefOrllluhllil)ll Sllld ie~ on Rifampicin Oinnnents P:m II. C0111 p;lra lil'c Elalu;lIioll of lhe \ ';lrioll~ Relc.!':>c ··Icrhnitlllc",," I)mg On:. '1IlJ. Pbllrm. 17. 31 i-.~1.~ (11)1)1).

17. \I.D. DiBi,lSC and C T Rhodes, "1m e." lig.l tion~ of Epidermal (;WII til Factor in Scmisolid Formulation ..... ' Pblfrm . . krll I/eII'. 66, 165- 169 (1 WI).

18. A Roll and, c. Dcmi chcli~ , J.( :. Ja lllou llt.: , ,lnd B. Shrum. "Innuenn.' of FOrlllllhlt ioll , RcccplOr Fluid, :lIlt! Ocdusiull un ill I'itro Drug Rcle:lsc fmlllli)pical Dosage Form:., L\illf[:111 ,\uto11l :ued FJtm -ThrulIg-h Diffu~ion Cdl," Pb(/r/Jf. RI'.f. 9. H1-X6 (1991).

19 . . \ 1. Foldvari, B. J !lni~, :1Il t! C.j.:sJ. O~'1Je j i(lfor, "· Ii>pic:'ll I)OS,lgC Form of Lipmol1l:l1 ' Ierracainc: Effect of Additivcs on tbe 11/ l 'it/"O Rdea,c ,lIld UI

" /1'0 l'fnC1CY,"]. COllfrul/n/ Ndl'fl.f1' 27, IlJJ -2()5 (11)93). 10. S.C :. Ch:Ut:lraj :lnd I. K:mfer, "Rcle:l,e of AcyrJm ir from Semi-Solid

D()~'lge Forms: a Semi-A utolllated Procedure U,>ing a Simpk Pll:\igh.,s Flul\ -Through Cell," 11If.]. Pbl/rm. 125,] 15-111 (1995).

21. S.c. Chall:lraj, J. SII .l rhrirk, ~lnd I. K:l nfer. " \ Simple Diffu,u)Jl Cell to ,\ lonitor Drug Rdc:l<;c f 1"0111 Semi-Solid DO~:lge Form<;," 1m.]. Pbi/rlJl. 120,119- 124 (IWi)

11. S.c. C:hattjraj and l. K:l11fcr, "'The hheniun Cdl': :1 NOId .\ppmKh to ,\ loniwr Drug l{ deN~ from Semi-Solid Dos:lge FOf11h:' llif. J. P/'i/rlll. 133, :;;9-63 (1996).

13. \ '. I~ Shah,.I. El kin '>, S.\ . 1,:1111, :! ndJ .P Skcl l ~, "J)eterllllll.lOOll o( 11/ 111m Drug Rclc:l'>C fmm I l ydnX"oni~tll1c (ream'>." 1111.]' Pbtlrm. 53. 5J-59 (I ()S().

24. P.P. Sanglwi and CC :. C ;ullim. "Colllp,lris(Hl of Diffusion Studie.., o( Ilydrocorti ..,one between the Fr:mz Cell and the Enh:lllcer Cell", Drug Ocr. hilI. Phfll'lll. , 19, ISH-15S5 (19tH).

1,. T Il iguchi, "Iblc o( UcicaSl' of .\ Itdir;lmcllts from Ointment Bases Conuining Drugs in Su"peJ1<;ion,'·]. Pbtll'lII. S(I. 50, S74-8i5 (1961).

26. \\ '. I Jiguchi, "An:ll y~i.., of D:II:1 on lhc 1\1cJic:l Ill ClH Rel ease from OintlllClllS,"]. P/}/trlll . So. 51, S02-H04 (1962).

17. \ .. P. Shah.J. Flki rh, J. I 1,lIlu.." CKIM)rizadeh, :mtIJ.P. Skel l ~, " III 1,1m Uelcase o( II ~ t!nu.:oru'iollc from ·lopic:11 Prcpar.1tic Ul' ,lilt! \momarcd Procedure," Pbi/rJII. RI'.f. 8, )5-59 (11)91).

2H.J.B. Li :md Pc. Ibhn, ",\ utom:ll ed Di~~olution Tc~tillg of Tc)pical Drug F(lrrnulatioim L\ing' Fr~m z Cdl~ :md I I PLC AIl:llr~i~." P/}(mll. Tl.'d). 17 (7), +I-54 (I l)l),).

29.\ '. P. Shah, J. S. Flkill.., and R. L. \ \ 'il li:l1m. In \ i[ro dnlg- rclc:Jsc mca­~ lI n.:l1)e11l for topic:!1 !-:lul"Oconicoid crC;I111 ... , Pb,mJIII(Qpol'ifll l'~rIIlJI. t 9, '(HH·~O~6 (199.;).

~(].J. D. Segcr .. ,J. I,. Z:ltZ :lntl \ '. P. ShHh, In I'itrt) relc:l~e of phenol fr( 111I lIilll111ent fOrlmti :ltioll. I)lrarm. 'hd, .. 21 (I), 70-S I (I tN7).

J I. \ . \\" . .. \(hl1l1'Oll, Phr~icil ChcllIi~try of Sllr~lCcs, 5th Ed ., \\,ilc ~'

Inter.riellcc, :sJY, 11)90, pp. WS-400. 31. J. L. Zarz. "Drug rclC~I'iC (rom serni,uliJs: cfft:ct of mcrnhr.mc pcr­

Ille'lhillt~ · on sen~itil it)" Ir) product jlar:llllclcrs. ,. P1;1I1"1II. RI'S., 12, 7H7-7H9 (I 'Ni).

'I. \. C. J)emirhc li ~, J-c. ,Lllnoulle :!nd B. ShroOl, "Influence o(for-11lul.nioll. recepwr fluid alld ocdu..,ion, nn in I ilm drug rcIc:l\c from topi­cil do",l!!e forlll~, thing-;III .1IItolll<llcd fl<J\I.through diffu .. ioJ1 cell, Pblfrm. RI'J., 9, S1-H6 (11)91).

.l..J.. J S. Elkins ,lIId \'. P. 5h:lh, Rolc of receptor mt:dia in in litro rc1c.l~e

SI't' Rcfcl-cnc.:cs . . {oII/illfll'd UII p(lge J 7

/)i.I)·o/lftiuII7hbll {}/ogic.dFEB R UARY 1998

R cfc l·CI1CCS . .. fUll lilllfl'l1 jiWlf pll,f!/ / 3. "rudie ... of crcam!!, Ph 'lrm. Rc~., II , S-46 (199+).

35. R.II. GU} , .1 .11. I b dgrolft, "On the Detcnnin!Hion uf Drug Relc~he Rate,,> frolll 'l ()pical DU">:Jgc Forms," /111. J. Pbllrlll. 60, R I-R3 (1990).

.\6. A. 11:I1I,lf, P.J. Chick ha le, and E,\ I. Pbkogi:lIlni ... , "A~'1cs"' l11e lll of Triethanobminc Salicrl:ltc Rcl c:Jsc from the DCf1n :ltolog i c~1 1 Ihsc.<. :mJ the

Commercia1 Product ... > PIJlIrIll. , Irttl /lrh'. 66, 321- .~2H (199 1). .n. ,\\'D. Vbchou, D.I\\. Rckbs, P.P. D:llhs. :Illd 1\'.11. Choulis,

"Den:loprncll t :lIld III I 'ill'o Ev:llwltiull of Griscofukin Gels U!iing Fr;HlI Diffmion Celis," 11I1.}. Pblll'lll. 82, 47-52 (1991).

JR \ '. P. Shah,J. Elkins, ;IIHIJ .P. Skelly, "Rdation<.,hip Bc['\\ccn/n 1'i'1'0 Skin Blanching ,md III I ,tro Rdc:bt: Rare for Ikl:UlIcthNHlC \ 'a lerone Crcarns,"]' I'bll l'lII. Sci. 81, 10+-106 (1991).

W. S.c. KU lIJU, A.D. Call1cron, 0L\\. Aldtl.cr ;mel '1'.\\ '. Quick, "Development :lnd \';llidatioll of i\1cdlOd for I)ctcrlllin:niun of III I 'ifro

Rclc:1Sl' of Rctinoic ,\Cid frolll Crc:lIl1'i." Dmg D!'i'. Illd. Plmrlll. t 9, 42 5-4JH (I 'I'll).

40 .. \1 . Corbo, T\\ '. Schu lt l., C;.t...: . \\ong :Jntl G.A. \':111 Bu<;ki rk, "Dcvelopmcnt ;Hld Va lidat ion of III I 'ifm Rcltca<;(' 'lb ting ,\ let hods for Semi~()lid F()rlllubli on~," IJhIWlIJ. ·Ii'd). 17 (9). 1 J1 -IlR (1993 ).

41. 1/ .1\ 1. F;lrcs ;Hlt! J. L. Z:l!l, "Me l"Urellll'1It or Drug Rclc:J'ic frOtn 'Illpicai C;e1~ L~sin g'l\I () ' I}pe~ of App:lr:It1!S," Pblfrm. ·Ii·d;. 19 (I), 52-58 (1'19;).

42 .JI,. Z;ltl,J, \ ':lr<;,Hlo, :Inti \ '.P. Sh;lh, "111 1'itl'o Rclc;J,c (II' Bet.IIIH.' th:J ~tlnc Dipropion.l lc from Pt'rrobtllm- Ba~cd

()inllllcnh," Pblfl'lIl. Dn', 7hh. I, 19J-298 (1996).

/Jhm/llliuII7i'c/Jll%gi('sI FEBR UA RY 1998


Recommended